Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Intervalo de año de publicación
1.
Br J Cancer ; 113(2): 354-63, 2015 Jul 14.
Artículo en Inglés | MEDLINE | ID: mdl-26103569

RESUMEN

BACKGROUND: The melanocortin-1-receptor (MC1R) gene regulates human pigmentation and is highly polymorphic in populations of European origins. The aims of this study were to evaluate the association between MC1R variants and the risk of non-melanoma skin cancer (NMSC), and to investigate whether risk estimates differed by phenotypic characteristics. METHODS: Data on 3527 NMSC cases and 9391 controls were gathered through the M-SKIP Project, an international pooled-analysis on MC1R, skin cancer and phenotypic characteristics. We calculated summary odds ratios (SOR) with random-effect models, and performed stratified analyses. RESULTS: Subjects carrying at least one MC1R variant had an increased risk of NMSC overall, basal cell carcinoma (BCC) and squamous cell carcinoma (SCC): SOR (95%CI) were 1.48 (1.24-1.76), 1.39 (1.15-1.69) and 1.61 (1.35-1.91), respectively. All of the investigated variants showed positive associations with NMSC, with consistent significant results obtained for V60L, D84E, V92M, R151C, R160W, R163Q and D294H: SOR (95%CI) ranged from 1.42 (1.19-1.70) for V60L to 2.66 (1.06-6.65) for D84E variant. In stratified analysis, there was no consistent pattern of association between MC1R and NMSC by skin type, but we consistently observed higher SORs for subjects without red hair. CONCLUSIONS: Our pooled-analysis highlighted a role of MC1R variants in NMSC development and suggested an effect modification by red hair colour phenotype.


Asunto(s)
Predisposición Genética a la Enfermedad , Receptor de Melanocortina Tipo 1/genética , Neoplasias Cutáneas/genética , Carcinoma Basocelular/genética , Carcinoma de Células Escamosas/genética , Color del Cabello , Humanos , Oportunidad Relativa , Fenotipo , Riesgo , Neoplasias Cutáneas/etiología
2.
Biochem Mol Biol Int ; 44(6): 1093-104, 1998 May.
Artículo en Inglés | MEDLINE | ID: mdl-9623762

RESUMEN

Human hepatoma cell line, HepG2, has been infected with vaccinia virus and synthesis of plasma proteins was determined by electroimmunoassay and corresponding mRNA's measured by Northern blotting. The inhibitory effect of the virus was dose- and time-dependent. Electrophoretic mobility shift assay revealed a decrease in C/EBP binding activities in nuclear extracts isolated from the infected hepatoma cells. Supershift analysis of the C/EBP isoforms showed alpha and beta subunit involvement in DNA binding. The treatment of the cells with interleukin-1, interleukin-6, and dexamethasone at the initial stage of infection appears to delay the virally induced inhibition of host cell protein synthesis. Thus, possible "protective" role of the acute phase cytokines in viral infection is proposed.


Asunto(s)
Proteínas de Fase Aguda/biosíntesis , Carcinoma Hepatocelular/metabolismo , Carcinoma Hepatocelular/virología , Interleucina-1/fisiología , Interleucina-6/fisiología , Neoplasias Hepáticas/metabolismo , Neoplasias Hepáticas/virología , Virus Vaccinia , Antineoplásicos Hormonales/farmacología , Dexametasona/farmacología , Humanos , Interleucina-1/farmacología , Interleucina-6/farmacología , ARN Mensajero/metabolismo , Células Tumorales Cultivadas , Vaccinia/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA